Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer
- Authors:
- M von Euler, KG Wiman, H Gabra, JD Brenton, B Basu, I Vergote, C Gourley, A Smith, J Alfredsson, N Mohelll, JA Green
- Journal:
- CANCER RESEARCH
- Citation info:
- Vol. 75
- Publication date:
- 1st Aug 2015
- Full text
- DOI